Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of a Digital Therapeutic [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating a digital therapeutic from Oui Therapeutics for suicidal ideation and suicide attempts has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Suicidal Ideation
• Suicide Attempt

Drugs mentioned

• Oui Digital Therapeutic

Snippet

Sponsor: Oui Therapeutics, Inc. | Conditions: Suicide, Attempted, Suicidal Ideation | Phase 2, Phase 3 | Status: TERMINATED